Drug Approval | November 09, 2023
Lupin launches Rocuronium Bromide injection in US
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
Subscribe To Our Newsletter & Stay Updated
